NO20001938L - Fremgangsmate for fremstilling av aryloksy-alkyl-dialkylaminer - Google Patents
Fremgangsmate for fremstilling av aryloksy-alkyl-dialkylaminerInfo
- Publication number
- NO20001938L NO20001938L NO20001938A NO20001938A NO20001938L NO 20001938 L NO20001938 L NO 20001938L NO 20001938 A NO20001938 A NO 20001938A NO 20001938 A NO20001938 A NO 20001938A NO 20001938 L NO20001938 L NO 20001938L
- Authority
- NO
- Norway
- Prior art keywords
- dialkylamines
- aryloxyalkyl
- preparation
- aryloxyalkyl dialkylamines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Detergent Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95081897A | 1997-10-15 | 1997-10-15 | |
| US09/161,653 US6005102A (en) | 1997-10-15 | 1998-09-28 | Aryloxy-alkyl-dialkylamines |
| PCT/US1998/021609 WO1999019293A1 (en) | 1997-10-15 | 1998-10-14 | Novel aryloxy-alkyl-dialkylamines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001938D0 NO20001938D0 (no) | 2000-04-13 |
| NO20001938L true NO20001938L (no) | 2000-06-07 |
Family
ID=26858006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001938A NO20001938L (no) | 1997-10-15 | 2000-04-13 | Fremgangsmate for fremstilling av aryloksy-alkyl-dialkylaminer |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP1025077B1 (pt) |
| JP (1) | JP2001519410A (pt) |
| KR (1) | KR100669836B1 (pt) |
| CN (1) | CN1231458C (pt) |
| AR (1) | AR015183A1 (pt) |
| AT (1) | ATE355264T1 (pt) |
| AU (1) | AU757630C (pt) |
| BR (1) | BR9813069A (pt) |
| CA (1) | CA2306343C (pt) |
| CY (1) | CY1106497T1 (pt) |
| DE (1) | DE69837210T2 (pt) |
| DK (1) | DK1025077T3 (pt) |
| EA (1) | EA003937B1 (pt) |
| EE (1) | EE200000225A (pt) |
| ES (1) | ES2281937T3 (pt) |
| HK (1) | HK1026889A1 (pt) |
| HU (1) | HUP0004419A3 (pt) |
| ID (1) | ID24417A (pt) |
| IL (2) | IL135343A0 (pt) |
| NO (1) | NO20001938L (pt) |
| NZ (1) | NZ503793A (pt) |
| PL (1) | PL198443B1 (pt) |
| PT (1) | PT1025077E (pt) |
| SI (1) | SI1025077T1 (pt) |
| SK (1) | SK286460B6 (pt) |
| TR (1) | TR200001012T2 (pt) |
| WO (1) | WO1999019293A1 (pt) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA66861C2 (uk) * | 1998-05-15 | 2004-06-15 | Уайт | 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування |
| US6479535B1 (en) | 1998-05-15 | 2002-11-12 | Wyeth | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
| WO2001019839A1 (en) * | 1999-09-13 | 2001-03-22 | American Home Products Corporation | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| AR029539A1 (es) | 2000-07-06 | 2003-07-02 | Wyeth Corp | Combinaciones de estatinas y agentes estrogenicos |
| WO2002003990A2 (en) | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted insole compounds for treating excessive intraocular pressure |
| US6358991B2 (en) | 2000-07-06 | 2002-03-19 | American Home Products Corporation | Methods of treating neuropeptide Y-related conditions |
| EP1656938A1 (en) | 2000-07-06 | 2006-05-17 | Wyeth | Combinations of SSRI and estrogenic agents |
| US6455568B2 (en) | 2000-07-06 | 2002-09-24 | Wyeth | Combination therapy for inhibiting sphincter incontinence |
| AR029538A1 (es) | 2000-07-06 | 2003-07-02 | Wyeth Corp | Composiciones farmaceuticas de agentes estrogenicos |
| US6369051B1 (en) | 2000-07-06 | 2002-04-09 | American Home Products Corporation | Combinations of SSRI and estrogenic agents |
| US6376486B1 (en) | 2000-07-06 | 2002-04-23 | American Home Products Corporation | Methods of inhibiting sphincter incontinence |
| AU2001273074A1 (en) | 2000-07-06 | 2002-01-21 | Wyeth | Combinations of ssri and estrogenic agents |
| EP1379493A2 (en) * | 2001-03-23 | 2004-01-14 | Eli Lilly and Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| EP1401446B1 (en) | 2001-05-22 | 2005-02-09 | Eli Lilly And Company | Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| JP2004531562A (ja) | 2001-05-22 | 2004-10-14 | イーライ・リリー・アンド・カンパニー | ２−置換１，２，３，４−テトラヒドロキノリンおよびその誘導体、組成物ならびに方法 |
| US7314937B2 (en) | 2002-03-21 | 2008-01-01 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
| US7098241B2 (en) | 2002-12-16 | 2006-08-29 | Hoffmann-La Roche Inc. | Thiophene hydroxamic acid derivatives |
| PA8629201A1 (es) * | 2004-04-07 | 2005-11-25 | Wyeth Corp | Polimorfo cristalino de acetato de bazedoxifeno |
| SG151331A1 (en) | 2004-04-07 | 2009-04-30 | Wyeth Corp | Crystalline polymorph of a bazedoxifene acetate |
| AU2005233128A1 (en) | 2004-04-08 | 2005-10-27 | Wyeth | Bazedoxifene ascorbate as selective estrogen receptor modulator |
| WO2006017639A2 (en) * | 2004-08-05 | 2006-02-16 | Wyeth | Crystalline polymorph of pipindoxifene hydrochloride monohydrate |
| TW200637803A (en) * | 2005-01-13 | 2006-11-01 | Wyeth Corp | Processes for the preparation of aminoethoxybenzyl alcohols |
| US20100087661A1 (en) * | 2007-02-12 | 2010-04-08 | Josef Jirman | Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole |
| US20100016582A1 (en) * | 2008-02-11 | 2010-01-21 | Wyeth | Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate |
| RU2011145811A (ru) * | 2009-04-13 | 2013-05-20 | Сандоз Аг | Способы синтеза базедоксифенацетата и его промежуточных продуктов |
| US8569483B2 (en) | 2011-06-21 | 2013-10-29 | Divi's Laboratories, Ltd. | Process for the preparation of bazedoxifene acetate and intermediates thereof |
| CN104151265B (zh) * | 2013-05-13 | 2016-10-05 | 上海医药工业研究院 | 醋酸巴多昔芬中间体的制备方法 |
| JP2016518449A (ja) | 2013-05-15 | 2016-06-23 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | インドール製剤を調製するためのプロセスおよび中間体 |
| IT201800006562A1 (it) * | 2018-06-21 | 2019-12-21 | Procedimento e intermedi utili per la preparazione di indoli | |
| IT201900001923A1 (it) | 2019-02-11 | 2020-08-11 | Erregierre Spa | Sali di bazedoxifene utili per la preparazione di bazedoxifene acetato |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH448121A (de) | 1963-03-13 | 1967-12-15 | Hoffmann La Roche | Verfahren zur Herstellung substituierter Hydrazinverbindungen |
| WO1991007107A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
| GB9326332D0 (en) | 1993-12-23 | 1994-02-23 | Karo Bio | Indole derivatives |
| EP0925063A4 (en) * | 1996-07-01 | 2000-12-27 | Lilly Co Eli | Blood-glucose-lowering and lipid-lowering compounds |
| JP2001513771A (ja) * | 1997-02-27 | 2001-09-04 | アメリカン・サイアナミド・カンパニー | マトリクス金属プロテイナーゼ阻害薬としてのｎ−ヒドロキシ−２−（アルキル、アリール、またはヘテロアリールスルファニル、スルフィニルまたはスルホニル）−３−置換アルキル、アリールまたはヘテロアリールアミド |
| AU7170798A (en) * | 1997-04-30 | 1998-11-24 | Eli Lilly And Company | Antithrombotic agents |
-
1998
- 1998-10-14 BR BR9813069-2A patent/BR9813069A/pt not_active Application Discontinuation
- 1998-10-14 NZ NZ503793A patent/NZ503793A/xx unknown
- 1998-10-14 EE EEP200000225A patent/EE200000225A/xx unknown
- 1998-10-14 CN CNB988121492A patent/CN1231458C/zh not_active Expired - Fee Related
- 1998-10-14 WO PCT/US1998/021609 patent/WO1999019293A1/en active IP Right Grant
- 1998-10-14 DE DE69837210T patent/DE69837210T2/de not_active Expired - Lifetime
- 1998-10-14 IL IL13534398A patent/IL135343A0/xx active IP Right Grant
- 1998-10-14 CA CA2306343A patent/CA2306343C/en not_active Expired - Fee Related
- 1998-10-14 SK SK537-2000A patent/SK286460B6/sk not_active IP Right Cessation
- 1998-10-14 EP EP98953459A patent/EP1025077B1/en not_active Expired - Lifetime
- 1998-10-14 PL PL339908A patent/PL198443B1/pl not_active IP Right Cessation
- 1998-10-14 DK DK98953459T patent/DK1025077T3/da active
- 1998-10-14 AT AT98953459T patent/ATE355264T1/de not_active IP Right Cessation
- 1998-10-14 ES ES98953459T patent/ES2281937T3/es not_active Expired - Lifetime
- 1998-10-14 HU HU0004419A patent/HUP0004419A3/hu unknown
- 1998-10-14 ID IDW20000680A patent/ID24417A/id unknown
- 1998-10-14 AU AU10831/99A patent/AU757630C/en not_active Ceased
- 1998-10-14 SI SI9830877T patent/SI1025077T1/sl unknown
- 1998-10-14 KR KR1020007004031A patent/KR100669836B1/ko not_active IP Right Cessation
- 1998-10-14 EP EP07003195A patent/EP1777214A3/en not_active Withdrawn
- 1998-10-14 AR ARP980105112A patent/AR015183A1/es unknown
- 1998-10-14 TR TR2000/01012T patent/TR200001012T2/xx unknown
- 1998-10-14 PT PT98953459T patent/PT1025077E/pt unknown
- 1998-10-14 EA EA200000416A patent/EA003937B1/ru not_active IP Right Cessation
- 1998-10-14 JP JP2000515866A patent/JP2001519410A/ja active Pending
-
2000
- 2000-03-29 IL IL135343A patent/IL135343A/en not_active IP Right Cessation
- 2000-04-13 NO NO20001938A patent/NO20001938L/no not_active Application Discontinuation
- 2000-09-26 HK HK00106079A patent/HK1026889A1/xx not_active IP Right Cessation
-
2007
- 2007-04-05 CY CY20071100491T patent/CY1106497T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001938L (no) | Fremgangsmate for fremstilling av aryloksy-alkyl-dialkylaminer | |
| DE69634256D1 (de) | Zementformulierung | |
| NO20021714D0 (no) | 2-fenyl-substituerte imidazotriazinoner, fremgangsmåte for fremstilling derav samt anvendelse av forbindelsene | |
| DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
| DE69912174D1 (de) | Verfahren zur Herstellung von Dialkanolaminen | |
| NO20003454L (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
| NO20023937D0 (no) | Fremgangsmåte for fremstilling av substituert tiazolidindion | |
| NO993912D0 (no) | Fremgangsmåte for fremstilling av eprosartan | |
| EE200000055A (et) | Protsess tsüklopropüülatsetüleeni valmistamiseks | |
| NO20000933L (no) | Fremgangsmõte for fremstilling av polymer | |
| NO306862B1 (no) | Fremgangsmåte for fremstilling av metylklorsilaner | |
| NO993913D0 (no) | Fremgangsmåte for fremstilling av eprosartan | |
| NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| NO985535D0 (no) | FremgangsmÕte for fremstilling av 1,3-alkandioler | |
| NO984905D0 (no) | FremgangsmÕte for fremstilling av b°rstevarer | |
| NO995388D0 (no) | Fremgangsmåte for fremstilling av formylfosfonsyre | |
| EE9900373A (et) | Protsess bensotiasoloonühendite valmistamiseks | |
| DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer | |
| DK0721929T3 (da) | Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner | |
| DK0863874T3 (da) | Fremgangsmåde til fremstilling af dioxoazabicyclohexaner | |
| NO20003077L (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
| NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
| NO20005743L (no) | Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |